Zura Bio ZURA
NASDAQ ZURA
$1.25 -0.18 (-12.94%)
As of: Nov 12, 2026 · 12:49 PM EST

Zura Bio (ZURA) Gains (Losses) on Sale of Assets & Investments (2021 - 2022)

Updated

Zura Bio's Gains (Losses) on Sale of Assets & Investments was $1.19 million in Q4 2022, up 73.5% from the prior quarter.

Analysis

Zura Bio (ZURA) Gains (Losses) on Sale of Assets & Investments (2021 - 2022) Analysis & Trends

For FY2022, Gains (Losses) on Sale of Assets & Investments at Zura Bio came in at $2.08 million.

  • In earlier years, Gains (Losses) on Sale of Assets & Investments was $19,054 in FY2021.
  • Per Business Quant data, ZURA's Gains (Losses) on Sale of Assets & Investments in the three quarters before Q4 2022 was $686,544 (Q3 2022), $181,213 (Q2 2022) and $16,299 (Q1 2022).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gains on Sales (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 Zura Bio 178.80 Mn -549.04 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2022 1.19 Mn
Sep 30, 2022 686,544.00
Jun 30, 2022 181,213.00
Mar 31, 2022 16,299.00
Sep 30, 2021 6,919.00
Mar 10, 2021 6,919.00
API Access

Zura Bio Gains (Losses) on Sale of Assets & Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-investment-income&ticker=ZURA&period=max&api_key=YOUR_API_KEY